M
Momokazu Gotoh
Researcher at Nagoya University
Publications - 346
Citations - 8463
Momokazu Gotoh is an academic researcher from Nagoya University. The author has contributed to research in topics: Overactive bladder & Urinary incontinence. The author has an hindex of 41, co-authored 334 publications receiving 7253 citations. Previous affiliations of Momokazu Gotoh include University of Texas Southwestern Medical Center & University of Tokyo.
Papers
More filters
Journal ArticleDOI
ICIQ: a brief and robust measure for evaluating the symptoms and impact of urinary incontinence.
TL;DR: To develop and evaluate the International Consultation on Incontinence Questionnaire (ICIQ), a new questionnaire to assess urinary incontinence and its impact on quality of life (QoL).
Journal ArticleDOI
Symptom assessment tool for overactive bladder syndrome—overactive bladder symptom score
Yukio Homma,Masaki Yoshida,Narihito Seki,Osamu Yokoyama,Hidehiro Kakizaki,Momokazu Gotoh,Tomonori Yamanishi,Osamu Yamaguchi,Masayuki Takeda,Osamu Nishizawa +9 more
TL;DR: The OABSS, the sum score of four symptoms (daytime frequency, nighttime frequency, urgency, and urgency incontinence), has been developed and validated and may be a useful tool for research and clinical practice.
Journal ArticleDOI
Clinical guidelines for overactive bladder.
Osamu Yamaguchi,Osamu Nishizawa,Masayuki Takeda,Osamu Yokoyama,Yukio Homma,Hidehiro Kakizaki,Kenji Obara,Momokazu Gotoh,Yasuhiko Igawa,Naarihito Seki,Masaki Yoshida +10 more
TL;DR: Department of Urology, Fukushima Medical University, Fukushima, Department of Urolog, Shinshu University School of Medicine, Matsumoto, Nagano, University of Yamanashi Interdisciplinary Graduate School of medicine and Engineering, Chuo,Yamanashi.
Journal ArticleDOI
The long-term outcome of laparoscopic radical nephrectomy for small renal cell carcinoma
TL;DR: Laroscopic radical nephrectomy can be an alternative to open neph rectomy in patients with localized small renal cell carcinoma and long-term results suggest that it is feasible to perform open surgery after laparoscopy in these patients.
Journal ArticleDOI
Phase III, randomised, double-blind, placebo-controlled study of the β3-adrenoceptor agonist mirabegron, 50 mg once daily, in Japanese patients with overactive bladder.
Osamu Yamaguchi,Eiji Marui,Hidehiro Kakizaki,Yukio Homma,Yasuhiko Igawa,Masayuki Takeda,Osamu Nishizawa,Momokazu Gotoh,Masaki Yoshida,Osamu Yokoyama,Narihito Seki,Yasushi Ikeda,Sumito Ohkawa +12 more
TL;DR: To evaluate the efficacy and safety of the β3‐adrenoceptor agonist mirabegron, in a Japanese population with overactive bladder (OAB).